Wall Street brokerages forecast that Invitae Corporation (NYSE:NVTA) will report earnings of ($0.55) per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Invitae Corporation’s earnings, with the lowest EPS estimate coming in at ($0.70) and the highest estimate coming in at ($0.47). Invitae Corporation reported earnings per share of ($0.69) during the same quarter last year, which would suggest a positive year-over-year growth rate of 20.3%. The company is expected to issue its next quarterly earnings report on Monday, February 12th.

On average, analysts expect that Invitae Corporation will report full-year earnings of ($2.45) per share for the current fiscal year, with EPS estimates ranging from ($2.58) to ($2.30). For the next year, analysts anticipate that the firm will report earnings of ($1.70) per share, with EPS estimates ranging from ($1.99) to ($1.38). Zacks’ EPS averages are an average based on a survey of sell-side research analysts that follow Invitae Corporation.

A number of research firms have commented on NVTA. BidaskClub upgraded shares of Invitae Corporation from a “sell” rating to a “hold” rating in a research note on Thursday, August 3rd. Zacks Investment Research upgraded shares of Invitae Corporation from a “hold” rating to a “strong-buy” rating and set a $11.00 price objective on the stock in a research note on Wednesday, October 11th. J P Morgan Chase & Co reiterated an “overweight” rating and set a $15.00 price objective (up from $14.00) on shares of Invitae Corporation in a research note on Wednesday, August 9th. Finally, Leerink Swann reduced their price target on shares of Invitae Corporation from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 7th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $13.50.

Several institutional investors have recently bought and sold shares of the company. Perceptive Advisors LLC lifted its position in shares of Invitae Corporation by 190.1% in the 3rd quarter. Perceptive Advisors LLC now owns 1,884,500 shares of the medical research company’s stock worth $17,657,000 after buying an additional 1,235,000 shares during the last quarter. Orbimed Advisors LLC lifted its position in shares of Invitae Corporation by 232.5% in the 3rd quarter. Orbimed Advisors LLC now owns 1,518,197 shares of the medical research company’s stock worth $14,226,000 after buying an additional 1,061,531 shares during the last quarter. Allianz Asset Management GmbH lifted its position in shares of Invitae Corporation by 110.6% in the 3rd quarter. Allianz Asset Management GmbH now owns 168,856 shares of the medical research company’s stock worth $1,582,000 after buying an additional 88,674 shares during the last quarter. OxFORD Asset Management LLP acquired a new stake in shares of Invitae Corporation in the 3rd quarter worth about $180,000. Finally, Schwab Charles Investment Management Inc. increased its holdings in shares of Invitae Corporation by 28.1% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 161,638 shares of the medical research company’s stock worth $1,515,000 after acquiring an additional 35,455 shares during the period. Institutional investors own 59.22% of the company’s stock.

Invitae Corporation (NYSE:NVTA) traded up $0.20 during midday trading on Tuesday, reaching $8.65. 437,600 shares of the company’s stock were exchanged, compared to its average volume of 128,881. Invitae Corporation has a 12-month low of $2.35 and a 12-month high of $8.68. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.61 and a current ratio of 2.61.

COPYRIGHT VIOLATION WARNING: “Zacks: Analysts Anticipate Invitae Corporation (NVTA) Will Post Earnings of -$0.55 Per Share” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://www.watchlistnews.com/zacks-analysts-anticipate-invitae-corporation-nvta-will-post-earnings-of-0-55-per-share/1724388.html.

About Invitae Corporation

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients.

Get a free copy of the Zacks research report on Invitae Corporation (NVTA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Invitae Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invitae Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.